Research / LEDS / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-21-036359 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
544.48% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-8.29% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
251.42% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
46.14% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-41.14% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
36.69% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.34% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Aug 31, 2021 0/9 normalized Level 3 Nov 30, 2021 0/9 normalized Level 3 Feb 28, 2022 0/9 normalized Level 3 May 31, 2022 8/9 normalized Level 3 Aug 31, 2022 8/9 normalized Level 3 Nov 30, 2022 8/9 normalized Level 3 Feb 28, 2023 8/9 normalized Level 3 May 31, 2023 9/9 normalized Level 3 Aug 31, 2023 9/9 normalized Level 3 Nov 30, 2023 9/9 normalized Level 3 Feb 29, 2024 9/9 normalized Level 3 May 31, 2024 9/9 normalized Level 3 Aug 31, 2024 9/9 normalized Level 3 Nov 30, 2024 9/9 normalized Level 3 Feb 28, 2025 9/9 normalized Level 3 May 31, 2025 9/9 normalized Level 3 Aug 31, 2025 9/9 normalized Level 3 Nov 30, 2025 9/9 normalized Level 3 Feb 28, 2026 9/9 normalized Level 3 May 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 646.77%
Current 544.48%
Delta -102.29% Capex Intensity Decreased
Previous 4.64%
Current 0.97%
Delta -3.67% Cash Generation Increased
Previous -59.12%
Current -13.97%
Delta 45.15% Inventory Pressure Increased
Previous 240.88%
Current 251.42%
Delta 10.55% Margin Increased
Previous 19.98%
Current 46.14%
Delta 26.16% Profitability Increased
Previous -42.04%
Current -41.14%
Delta 0.90% R And D Intensity Increased
Previous 23.88%
Current 36.69%
Delta 12.81% Sbc Intensity Decreased
Previous 5.47%
Current 3.34%
Delta -2.14% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.